BOULDER, Colo., June 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will present at the Goldman Sachs 38th Annual Global Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: |
Goldman Sachs 38th Annual Global Healthcare Conference |
Presenter: |
Andy Robbins, Chief Operating Officer |
Date: |
Tuesday, June 13, 2017 |
Time: |
10:00 a.m. Pacific Time |
Webcast: |
https://cc.talkpoint.com/gold006/061317a_as/?entity=52_O16UKUL |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Array-owned or partnered drugs are advancing in registration studies: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), larotrectinib (partnered with Loxo Oncology), tucatinib (partnered with Cascadian Therapeutics) and ipatasertib (partnered with Roche).
CONTACT: |
Tricia Haugeto |
Array BioPharma Inc. |
|
303-386-1193 |
|
SOURCE Array BioPharma Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article